Pharmacological characterization of P2X7 receptors in rat peritoneal cells

Inflammation Research

Volumn 54, Issue 3, 2005, Pages 119-126

  Chen, Y W ^a   Donnelly Roberts, D L ^a   Namovic, M T ^a   Gintant, G A ^a   Cox, B F ^a   Jarvis, M F ^a   Harris, R R ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Flowcytometry; IL 1 ; P2X7

Indexed keywords

2' 3' O (4 BENZOYLBENZOYL)ADENOSINE 5' TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ETHIDIUM BROMIDE; INTERLEUKIN 1BETA; PHOSPHATE 6 AZOPHENYL 2' 4' DISULFONIC ACID; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CALCIUM; CD3 ANTIGEN; DRUG DERIVATIVE; ETHIDIUM; INTERLEUKIN 1; INTERLEUKIN 18; LACTATE DEHYDROGENASE; LIGAND; LIPOPOLYSACCHARIDE; PURINE P2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ANIMAL CELL; ARTICLE; ASTROCYTOMA CELL; CALCIUM TRANSPORT; CELL ISOLATION; CHANNEL GATING; CONTROLLED STUDY; CYTOKINE RELEASE; FLUOROMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PERITONEUM CELL; PERITONEUM LAVAGE; RAT; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; FLOW CYTOMETRY; INFLAMMATION; MACROPHAGE; METABOLISM; PERITONEUM; PHYSIOLOGY; TIME;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD3; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHIDIUM; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-18; L-LACTATE DEHYDROGENASE; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; PERITONEUM; PLATELET AGGREGATION INHIBITORS; PYRIDOXAL PHOSPHATE; RATS; RECEPTORS, PURINERGIC P2; TIME FACTORS; TRANSFECTION;

EID: 20044382685     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1332-7     Document Type: Article

References (43)

1. 7: cloning and expression of a human cDNA. J Biol Chem 1997; 272: 5482-6.
2. 7 nucleotide receptor mediation of membrane pore formation in human promyelocytes and neutrophils. J Immuol 2001; 167: 6754-63.
3. Sluyter R, Barden JA, Wiley JS. Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 2001; 304: 231-6.
4. 7 receptor of microglial cells: A novel immunomodulatory receptor. In Progress in Brain Research (P. Illes and H. Zimmermann, eds.) Elsevier Science BV, 1999; p355-68.
5. 7 receptor in immune cells of the brain and periphery. J Biol Chem 2001; 276: 23262-7.
6. 7 receptor. Neuropharmacol. 1997; 36: 1277-83.
7. Gomperts BD. Involvement of guanine nucleotide-binding protein in the gating Ca2+ by receptors. Nature 1983; 306: 64-6.
8. Sudo N, Tanaka K, Koga Y, Okumura Y, Kubo C, Nomoto K. Extracellular ATP activates mast cells via a mechanism different from the activation induced by cross-linking of Fc receptors. J Immunol 1996; 156: 3970-9.
9. 7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol 1999; 163: 1958-65.
10. Tenneti L, Gibbons SJ, Talamo BR. Expression and trans-synaptic regulation of P2X4 and P2Z receptors for extracellular ATP in parotid acinar cells. J Biol Chem 1998; 273: 26799-808.
11. 7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 1999; 112: 297-305.
12. 7). Science 1996; 272: 735-8.
13. Dubyak GR, el-Moatassim C. Signal transduction via P2 purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993; 265: (3 pt 1). C577-606.
14. Perregaux DG, McNiff P, Laliberte R, Maryrose C, Gabel C. ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood. J Immunol 2000; 165: 4615-23.
15. Mehta VB, Hart J, Wewers MD. ATP-stimulated release of IL-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem 2001; 276: 3820-6.
16. Grahames CBA, Michel AD, Chessel IP, Humphrey PPA. Pharmacological characterization of ATP- and LPS-induced IL-1β release in human monocytes. British J. Pharmacol. 1999; 127: 1915-21.
17. Ferrai D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J Expt Med 1997; 185: 579-82.
18. 7 receptors. J Boil Chem 2003; 278: 30732-40.
19. 7 receptor alters leukocyte function and attenuate an inflammatory response. J. Immunol. 2002; 168: 6436-45.
20. 7 receptor function. N-S Arch. Pharmacol. 1999; 359: 102-9.
21. Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM et al. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 1999; 376: 127-38.
22. 7R) induced pore formation in human THP-1 cells. J Pharmacol Exp Ther 2004; 308: 1053-61.
23. 7 receptor. Brit J Pharmacol 1998; 124: 1314-20.
24. 7 purinoreceptor in mouse NTW8 microglial cells. Brit J Pharmacol 1997; 121: 1429: 37.
25. Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthetase expression in RAW 264.7 Macrophages J Biol Chem 1998; 273: 27170-5.
26. 7 receptors in mouse parotid acinar and duct cells. J Biol Chem 2003; 278: 47544-61.
27. Lammas DA, Stober C, Harvey CJ, Kendrick N, Pamchalingam S, Kumararatne DS. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 1997; 7: 433-44.
28. Falzoni S, Munerati M, Ferrai D, Spisani S, Moretti S, Di Virgilio F. The puringergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 1995; 95: 1207-16.
29. 7 receptor. J Cell Biol 1997; 138: 697-706.
30. 7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 2003; 73: 361-9.
31. 7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promeylocytes and neutrophils. J. Immunol. 2001; 166: 6754-63.
32. 7-like-mediated calcium entry. FEBS Letters 2003; 538: 71-6.
33. 7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neruochem 2002; 81: 1196-211.
34. Jacobson KA, Jarvis MF, Williams M. Purine and pyrimidine (P2) receptors as drug targets. J Medicinal Chem 2002; 45: 4057-93.
35. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-67.
36. 7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J Immunol 2004; 172: 4987-94
37. 7 receptor. Neuropharmacology 1997; 36: 1285-94.
38. 2+ entry differentially contribute to the release of IL-1β and IL-1α from murine macrophages. J Immunol 2003: 170: 3029-36.
39. 7-mediated cell death via a capspase-1-dependent mechanism independently of cytokine production. J Biol Chem 2002; 277: 3210-8.
40. + release. Am J Cell Physiol 2004; 286: C1100-8.
41. Perregaux DG, Gable CA. Post-translational processing of murine IL-1: Evidence that ATP-induced release of IL-1α and IL-1β occurs via a similar mechanism. J Immunol 1998; 160: 2469-77.
42. 7 antagonist, oxidized ATP, in arthritic rats. Neurosci Lett 2002; 327: 87-90
43. 7 ATP receptor inhibitor, oxidized ATP. Arthritis and Rheumatism 2003; 46: 3378-85.